ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 ...
ICON plc Acquires Remaining 30% Stake in Beacon Bioscience Inc. DUBLIN, Ireland--(BUSINESS WIRE)--Jan 8, 2009 - ICON plc (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development ...
A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 12.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...
Icon PLC (ICLR) came out with quarterly earnings of $3.35 per share, missing the Zacks Consensus Estimate of $3.85 per share. This compares to earnings of $3.30 per share a year ago. These figures are ...
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the Board of his decision to retire as Chief Executive Officer and the Board ...
Dublin, Ireland, 17 April, 2013 – ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, in conjunction with ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and ...
Hosted on MSN
Icon PLC (ICLR) Beats Q1 Earnings Estimates
Icon PLC (ICLR) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.08 per share. This compares to earnings of $3.47 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback